Blog - CHIPSA Hospital: Gerson Therapy Center Cancer Treatment

Historic Event Unites 22 Late-Stage Cancer Survivors with Top Scientists From Around the World!

Last November, CHIPSA Hospital hosted a unique, first-of-its-kind event celebrating the lives of 22 late stage cancer survivors who, according to doctors, shouldn’t even be alive. Surrounded by world-renowned doctors, scientists, and researchers, these patients shared their inspiring stories of how they healed their terminal disease when conventional treatment had failed them. CHIPSA is not an […]

What Causes a Durable Cancer Remission?

Cancer relapse is unfortunately all too common in patients who were told their disease was eradicated. We’ve all heard of the patient who receives a clear diagnosis, only to be stricken with cancer yet again. Why is it that the cancer came back? Why didn’t the remission last? This is exactly what scientists are trying to figure out […]

Cancer Patient’s 10-Centimeter Tumor Disappears After Eight Weeks at CHIPSA Hospital

John Dilday was diagnosed with stage 4 squamous cell and basal cell carcinoma in his neck over three years ago. Last year, John had developed a fluid-filled sac on his neck that began to change, harden, and grow. The growth eventually spread throughout his throat all the way to the other side of his neck. Having […]

How Russell Weatherspoon Beat Terminal Lymphoma at CHIPSA Hospital!

Russell Weatherspoon was given 6 months to live back in 2018 after his non-Hodgkin’s lymphoma spread to his skin. But now, nearly 14 months later, he is alive, well, and eager to share his story. Russell’s journey began when he noticed a swollen lymph node near his elbow back in 2016. None of his doctors […]

From Wheelchair To Walking! How Amanda Leverett Davis Beat Cancer at CHIPSA.

Amanda Leverett Davis was diagnosed with an aggressive bone cancer called chondroblastic osteosarcoma in March of 2017. By the time her doctors discovered it, the disease had metastasized and advanced to stage 3. Amanda was told it was non-curative. But nearly two years after her initial diagnosis, Amanda is still alive to share her story, and […]

Keytruda Now FDA-Approved for Patients with Melanoma

The KEYNOTE-054 Phase 3 clinical trial (NCT02362594) showed that the immune checkpoint inhibitor drug Keytruda decreased the risk of melanoma recurrence or death by 43% in comparison to a placebo drug. The drug has thus been approved by the U.S. Food and Drug Administration (FDA) to treat patients with stage-3 melanoma (cancer has spread to […]

A New Lease on Life: How Amanda Leverett Davis Overcame Stage-3 Osteosarcoma at CHIPSA Hospital

Amanda Leverett Davis came to CHIPSA Hospital last October looking for ways to improve her quality of life after surgery, radiation, and chemotherapy failed to treat her late-stage cancer. But she believes CHIPSA did more than that. According to her, not only did they improve her quality of life, they also extended it. Amanda was diagnosed in […]

Research Team Discovers New Immune “Checkpoint” Protein

A recent report in the journal Cell showed that a team led by Vanderbilt researchers has found a new “checkpoint” protein on immune system cells in active, malignant tumors. In mouse models, blocking this protein, along with using other treatments, has been an effective approach to treating cancerous cells. Checkpoint proteins are an important component of […]

How Charlotte Trainer Beat Stage-4 Cancer at CHIPSA Hospital!

How Charlotte Trainer Beat Stage 4 Cancer at CHIPSA Hospital Charlotte Trainer thought she was out of options when she was diagnosed with Stage-4 inoperable Endometrial cancer in November of 2017. After having a full hysterectomy and 25 rounds of radiation, her doctors told her that the cancer had metastasized to her lungs. There was […]

Study Shows Better Immunotherapy Outcomes in Tumors with More Mutations

A recent study published in Nature Genetics called “Tumor mutational load predicts survival after immunotherapy across multiple cancer types” revealed that tumors with more mutations had better results with immunotherapy treatment. The study looked at data from 1,662 metastatic cancer patients who received checkpoint inhibitor therapy, and data from over 5,000 patients who were not treated […]

1 2 3 … 15 Next »